drugset / Trial / NCT01239719

Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

NCT01239719

Phase 3 Unknown 96 enrolled Azidus Brasil
RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of this study is to prove the efficacy of the dexamethasone 0.5 mg + 1 mg clemastine fumarate tablet compared to 0.5 mg of dexamethasone in reducing the signs and symptoms of allergic dermatitis.

Timeline

Start
2011-03
Primary completion
2011-07
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Clemastine Small molecule 1 mg
Subject Dexamethasone Small molecule 0.5 mg